Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines
NCT01237977
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
314
Enrollment
INDUSTRY
Sponsor class
Conditions
Skin Aging
Interventions
DRUG:
Botulinum Toxin Type A(Meditoxin®)
DRUG:
Botulinum Toxin Type A(Botox®)
Sponsor
Medy-Tox